Wall Street Analysts Lower Life Tech Estimates Following Disappointing Q2 Results | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Following disappointing second quarter financial results, a number of Wall Street analysts have lowered their top- and bottom-line estimates for Life Technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.